PPH icon

VanEck Pharmaceutical ETF

43 hedge funds and large institutions have $129M invested in VanEck Pharmaceutical ETF in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

2% more call options, than puts

Call options by funds: $819K | Put options by funds: $802K

0% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 12

Holders
43
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$819K
Puts
$802K
Net Calls
Net Calls Change

Top Buyers

1 +$41.1M
2 +$22.8M
3 +$11.4M
4
Wells Fargo
Wells Fargo
California
+$8.53M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$5.69M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$48.1M
2
$22.8M
3
$20.7M
4
$13.1M
5
$9M
6
$5.74M
7
$2.79M
8
$1.41M
9
$1.03M
10
$742K
11
$643K
12
$619K
13
$573K
14
$553K
15
$283K
16
$278K
17
$191K
18
$143K
19
$111K
20
$89K
21
$57K
22
$46K
23
$44K
24
$34.2K
25
$32K